Literature DB >> 19162250

The role of innate immune responses in autoimmune disease development.

Hanspeter Waldner1.   

Abstract

Autoimmune diseases are systemic or organ-specific disorders that are the result of an attack of the immune system against the body's own tissue. Development of autoimmune disease is generally avoided by distinct mechanisms that silence adaptive self-reactive T or B cells. The innate immune system is critically involved in the defense against pathogens and the induction of primary adaptive immune responses. Toll-like receptors (TLRs) are key receptors that activate the innate immunity in response to pathogen recognition. Recent data show that activation of innate immune cells such as dendritic cells (DCs) can break this state of tolerance and induce autoimmunity by priming autoreactive T cells. Here we review recent examples of how innate immune responses influence the adaptive immunity in the induction or regulation of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162250     DOI: 10.1016/j.autrev.2008.12.019

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  37 in total

1.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

2.  Engineering Biomaterials to Direct Innate Immunity.

Authors:  R S Oakes; E Froimchuk; C M Jewell
Journal:  Adv Ther (Weinh)       Date:  2019-02-27

Review 3.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

4.  Cofactors required for TLR7- and TLR9-dependent innate immune responses.

Authors:  Chih-Yuan Chiang; Alex Engel; Amanda M Opaluch; Irene Ramos; Ana M Maestre; Ismael Secundino; Paul D De Jesus; Quy T Nguyen; Genevieve Welch; Ghislain M C Bonamy; Loren J Miraglia; Anthony P Orth; Victor Nizet; Ana Fernandez-Sesma; Yingyao Zhou; Gregory M Barton; Sumit K Chanda
Journal:  Cell Host Microbe       Date:  2012-03-15       Impact factor: 21.023

5.  The role of TLR4 activation in photoreceptor mitochondrial oxidative stress.

Authors:  MinHee K Ko; Sindhu Saraswathy; Jignesh G Parikh; Narsing A Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

6.  Mannose binding lectin mediated complement pathway in multiple sclerosis.

Authors:  Janet Y Kwok; Florin Vaida; Ryan M Augst; Denise Y Yu; Kumud K Singh
Journal:  J Neuroimmunol       Date:  2011-09-10       Impact factor: 3.478

7.  Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.

Authors:  Bernd Jahrsdörfer; Angelika Vollmer; Sue E Blackwell; Julia Maier; Kai Sontheimer; Thamara Beyer; Birgit Mandel; Oleg Lunov; Kyrylo Tron; G Ulrich Nienhaus; Thomas Simmet; Klaus-Michael Debatin; George J Weiner; Dorit Fabricius
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

8.  Serum soluble triggering receptor on myeloid cells-1 (sTREM-1) is elevated in systemic lupus erythematosus but does not distinguish between lupus alone and concurrent infection.

Authors:  Yair Molad; Elisheva Pokroy-Shapira; Tania Kaptzan; Assaf Monselise; Michal Shalita-Chesner; Yehudit Monselise
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

9.  RNase L Reprograms Translation by Widespread mRNA Turnover Escaped by Antiviral mRNAs.

Authors:  James M Burke; Stephanie L Moon; Tyler Matheny; Roy Parker
Journal:  Mol Cell       Date:  2019-09-04       Impact factor: 17.970

10.  The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors.

Authors:  Changwen Deng; Jingjing Zhao; Shixin Zhou; Jiebin Dong; Jixiang Cao; Junshuang Gao; Yun Bai; Hongkui Deng
Journal:  Mol Ther       Date:  2019-10-18       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.